Disabled people four times worse off financially

22 Jul 2019

Disabled people are 4 times worse off financially than non-disabled people, according to new research commissioned by the Disability Benefit Consortium (DBC).

The study found that while people who receive welfare support have experienced cuts averaging £300, disabled people are typically £1,200 out of pocket annually.

The research was the first study looking specifically at the impact of welfare changes on disabled people over the last 10 years, and found:

Exposure of babies to topiramate and valproate in womb linked to birth defects, study suggests

1 Jul 2019

A new study in Neurology has shown an increased risk of birth defects in babies born to mothers taking medicines valproic acid and topiramate.

Study authors Pierre-Olivier Blotière and colleagues wanted to look at risks of birth defects to babies being exposed to 10 different epilepsy medicines in pregnancy. They were lamotrigine, pregabalin, clonazepam, valproic acid, levetiracetam, topiramate, carbamazepine, gabapentin, oxcarbazepine and phenobarbital.

Prescription from UK specialist made for nine-year-old whose cannabis-based medicine was confiscated at the airport

12 Apr 2019

A nine-year-old girl, whose cannabis oil had been confiscated at the airport on Saturday, has been given a prescription for the medicine from a UK specialist. 

Teagan's cannabis oil had been confiscated at the airport after her mother Emma Appleby brought the three-month supply into the UK illegally from the Netherlands on 6 April.

Some epilepsy medicines “cannot be stockpiled”, NHS list reveals

9 Apr 2019

On 3 April, BBC Newsnight reported that some medicines, including some for epilepsy, bipolar disorder and neuropathic pain, cannot be stockpiled.

This comes after the Health Secretary Matthew Hancock said in parliament that medical suppliers had been asked to stockpile an extra six-weeks’ worth of medicines. This is to ensure medicine supply continues in all Brexit scenarios.

Changes to prescribing rules around pregabalin and gabapentin following reclassification as controlled medicines from 1 April

13 Mar 2019

Epilepsy medicines pregabalin and gabapentin will be reclassified as controlled medicines under the Misuse of Drugs Act 1971 from 1 April 2019, NHS England has said.

This means there will be stricter legal controls over these medicines to prevent them from being misused, causing harm or being sourced illegally.